ural bleeding. Three studies reported
greater symptomatic improvement with MPFF treatment. Based on these results, MPFF may help to reduce
postprocedural pain, hemorrhage, and CVD-speciﬁc
symptoms. These beneﬁts appear to be greater when
treatment is started 2 weeks before the procedure.
When VAD treatment was started only after varicose
veins surgery,117 no beneﬁt was noted.
In a nonrandomized